Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 50 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Gabriela D.

Virgin Islands, United States

USD 50 /hr

Biochemist, PH. D | Laboratory Science | Clinical Research with 20+ years of experience.

Profile Summary

Permanent Resident US. Green Card holder. A published and accomplished scientist for over 20 years. Experience in human health; she excels as a trainer, both of biochemical and medical staff. Solid clinical and translational research lines have provided credible and trusted advisors amongst multidisciplinary teams (engineers, clinicians, biologist, biochemist), acting as the liaison between government agencies, pharmaceutical corporation and the scientific community. • Oversees Government of the City of Buenos Aires, Hospital of Infectious Diseases’ F. J. Muñiz’. Owns and runs the Haemostasis and Thrombosis Laboratory in the Biochemistry Department. At the same time, managing and adjusting lab protocols per each pandemic and epidemic such as AIDS, Hanta, Yellow Fever, H1N1, Antrax, Dengue, Tuberculosis, COVID-19. • Constantly ensuring lab safety standards are met and completing international protocols compliance. Building employee experience by addressing team morale matters and offering guidance to junior scientists, and supports peers. • Standardizing new technology and tests by supervising and teaching postgraduate biochemistry fellows. Creating requirements for bidding and quality for budget restraints and completing risk and quality assurance. • Member of the Research Ethics Committee at Hospital of Infectious Diseases’ F. J. Muñiz’, City of Buenos Aires. • Researcher of National Council for Scientific and Technical Research (CONICET). • Reviewer member at the Ministry of Science, Technology, and Productive Innovation, National Agency for Scientific and Technological Promotion. • Coordinates the end-to-end deployment of the Research, training, development and technology transfer platform. While managing project budgeting - devising annual reports to the hospital board of directors. Continuously and currently supervising dissertation fellowships and three Doctoral Fellows. • Advisor to the Advisory Commission in Health Research for the Ministry of Health • A current faculty member at Italian Hospital University Institute as Director of Postgraduate Courses. • A current faculty member at Hospital of Infectious Diseases’ F. J. Muñiz’ for Lectures on Infectious Diseases in the Hospital’s Teaching Unit of the University of Buenos Aires. INNOVATION AND ENTREPRENEURSHIP EchA-2022 Driving Phase III Trial Using Echinochroma A (EchA) in Persistent COVID-19 Patients + MedTech. EchA is a pigment derived from sea urchins that is known for its antioxidant power and its proven benefits for human health, especially heart disease and inflammatory pathologies, with a low level of toxicity and high bioavailability, so it is hypothesized that it will contribute benefits highly positive clinical trials in patients with persistent COVID syndrome. Winners of founds from Argentine Ministry of Science and Technology Hantavirus. Indrustry 4.0-2022 Technological program that helps in the mapping of the situation room on Hantavirus in the Andean Region of Argentina. Real-time data on the situation of sugarcane flowering, rodents, active cases of people and the use of an adjuvant treatment based on sea urchin roe. Winners of funds from the Federal Council of Science and Technology (COFECyT). TuneVid Application-2020 Qualified for the XPRIZE Rapid Covid Testing Competition Semi-final. This project aimed at obtaining a methodology for indirect detection of the presence of Covid-19. Developed prototype into a minimum viable product. Localized the App’s instructions targeted at a vulnerable and uneducated population. Transparency Application-2020 Supported the Hackathon MIT COVID-19 Challenge June 2020 winners. Provided guidance across health data sources to pull accurate metrics dashboards at national level. IncuBAte2019 Promotes innovation oriented to science as a profitable entrepreneurship through the IncuBAte Fund, a program that stimulates the strengthening and consolidation of innovative ventures in the City of Buenos Aires, through personalized support and the possibility of accessing a Non-Refundable Contribution and a workspace. This ongoing project, supported by the government of the City of Buenos Aires, is focused on developing a hepatotoxicity prediction test associated with antituberculosis drugs. ACCOMPLISHMENTS • Received 41 Awards/distinctions/scholarships “The World Travel Grant”, awarded by The International Society on Thrombosis and Haemostasis, International Congress. Since 2003. “Best Work in Obstetrics Award”, awarded by XXXIII Argentine Congress of Gynecology and Obstetrics. Research title: What's New in Obstetric Antiphospholipid Syndrome. Extra-criteria and its Impact on Postpartum Thrombosis. 2019, Tucumán, Argentina. “Alberto Peralta Ramos Award” for Best Work in Toco-Gynecology, awarded by Board of Directors of the H. National Academy of Medicine. Research title: Recurrent Pregnancy Loss: New horizons Over Old Mechanisms. This Prize is awarded by competition to the best work on "Toco-Gynecology". 2017, Buenos Aires, Argentina. “Best Work in Infectiology” awarded by XVII Argentine Congress of Infectiology. Research title: Pharmacogenetics of Tuberculosis: New Prediction Model of Hepatotoxicity Induced by Antituberculosis Drugs. 2017, Buenos Aires, Argentina. “Best Work in Clinical Research Award” for Infectiology, Inflammation and Immunology Category, awarded by The Argentine Society of Clinical Research. Research title: Role of Protein S and TAM Receptors Tyrosine Kinase in the Immunoregulation of Inflammatory Bowel Diseases. 2015, Buenos Aires, Argentina "Juan Antonio Sanchez Award” for Improving the Teaching of Laboratory Sciences, awarded by the Biochemistry Foundation. Book title: Fundamentals for Practical Management in the Hemostasis Laboratory. 2014, Buenos Aires, Argentina. • Delivered 66 presentations at international conferences and 74 at national conferences. • Reviews international work for different scientific journals. • Participated as an active member, coordinated post session, and reviewed scientific papers and speakers at 214 national and international conferences . • Takes an active role as a member of the International Society of Haemostasis and Thrombosis (ISTH), Grupo Cooperativo Argentino de Hemostasia y Thrombosis, Grupo CATH.

Subject Matter Expertise

• ☆ Biostatistics
• ☆ Biochemistry
• ☆ Biochemical Assays
• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Genetics
• ☆ PCR
• ☆ Data Collection
• ☆ Biomarker Discovery
• ☆ Decision Science
• ☆ Human Biology
• ☆ Women's Health
• ☆ Obstetrics & Gynecology
• ☆ Precision Medicine
• ☆ Gastroenterology & Hepatology
• ☆ Hepatitis
• ☆ Hematology
• ☆ Hematology-Oncology
• ☆ Infectious Disease
• ☆ Viral Diseases
• ☆ COVID-19
• ☆ Syphilis
• ☆ Bacterial Diseases
• ☆ Leprosy
• ☆ HIV/AIDS Treatment
• ☆ Tropical Medicine
• ☆ Malaria
• ☆ Clinical Laboratory Science
• ☆ Clinical Pathology
• ☆ Clinical Biochemistry
• ☆ Traditional Medicine
• ☆ Pregnancy & Childbirth
• ☆ Medical Sciences
• ☆ Inflammation

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Technical Writing

Research Market Research, Fact Checking, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Data Visualization, Big Data Analytics, Data Processing

Product Development Formulation, Product Validation, Concept Development, Prototyping

Work Experience

Health Research consultant

Hospital of Infectious Diseases F. J. Muñiz

January 2020 - Present

Facultaty Member

Italian Hospital University Institute

January 2015 - Present

Facultaty Member

University of Buenos Aires

January 2010 - Present

Clinical Research Scientist

Hospital of Infectious Diseases F. J. Muñiz

January 2005 - Present

Hospital of Infectious Diseases F. J. Muñiz

March 1991 - Present

Education

Researcher

National Scientific and Technical Research Council

2015 - Present

Researcher (ndependent Researcher of the Researcher Career of the Government of the Buenos Aires City)

Buenos Aires Ciudad

2005 - Present

PhD

University of Buenos Aires

2010 - 2015

Biochemistry

University of Buenos Aires

March 1983 - July 1989

Certifications

• Certificate in Protection of Human Participants Research

  National Institutes of Health-USA

  January 2021 - Present

• Certificate in Entrepreneurship

  Instituto Argentino de la Empresa (and Inter-American Development Bank LAB)

  December 2019 - Present

• Ph.D. in Health Sciences

  University of Buenos Aires

  December 2015 - Present

• Certificate in Epidemiology Applied to the Study of Thrombosis and Haemostasis

  International Society of Haemostasis and Thrombosis

  October 2009 - Present

• Certificate in Population Genetics

  University of Buenos Aires

  August 2007 - Present

• Certificate in Diagnostic Molecular Biology

  University of Buenos Aires

  July 2006 - Present

• Specialization Diploma in Statistics for Health Sciences

  University of Buenos Aires

  December 2005 - Present

• Specialization Diploma in Haemostasis and Thrombosis

  Academia Nacional de Medicina, Buenos Aires

  March 2003 - Present

• B.A in Biochemistry

  University of Buenos Aires

  October 1989 - Present

Publications

JOURNAL ARTICLE

José Omar Latino, Sebastián Udry, Federico Aranda, Silvia Perés Wingeyer, Diego Santiago Fernández Romero, Cristina Belizna, Gabriela de Larrañaga(2020). Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine . Lupus. p. 096120332095285. {SAGE} Publications

Sebastián Udry, José Omar Latino, Cristina Belizna, Silvia Perés Wingeyer, Diego Santiago Fernández Romero, Gabriela de Larrañaga(2019). A high-risk laboratory profile of antiphospholipid antibodies and thrombosis is associated with a large number of extra-criteria manifestations in obstetric antiphospholipid syndrome . Immunologic Research. 67. (6). p. 478--485. Springer Science and Business Media {LLC}

Jose Omar Latino, Sebastián Udry, Silvia Perés Wingeyer, Diego Fernández Romero, Paula Micone, Gabriela de Larrañaga(2018). What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients? . Immunologic Research. 66. (5). p. 577--583. Springer Nature

Perés Wingeyer S, Aranda F, Udry S, Latino J, de Larrañaga G(2018). Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort . Medicina clinica.

Aranda F, Udry S, Perés Wingeyer S, Amshoff LC, Bogdanova N, Wieacker P, Latino JO, Markoff A, de Larrañaga G(2018). Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications . Journal of assisted reproduction and genetics.

Perés Wingeyer, S., Aranda, F., Udry, S., Latino, J., de Larrañaga, G.(2018). Inherited thrombophilia and pregnancy loss. Study of an Argentinian cohort,Trombofilia hereditaria y pérdidas de embarazo. Estudio de una cohorte de Argentina . Medicina Clinica.

Aranda, F., Udry, S., Perés Wingeyer, S., Amshoff, L.C., Bogdanova, N., Wieacker, P., Latino, J.O., Markoff, A., de Larrañaga, G.(2018). Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications . Journal of Assisted Reproduction and Genetics. p. 1-8.

Chamorro JG, Castagnino JP, Aidar O, Musella RM, Frías A, Visca M, Nogueras M, Costa L, Perez A, Caradonna F, et al.(2017). Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity . Pharmacogenetics and genomics.

Alicia M. Sambuelli, Gabriela F. de Larrañaga, Paula Chavero, Anibal H. Gil, Silvia Negreira, Silvina A. Goncalves, Maricel I. Bellicoso, Sergio P. Huernos, Andrea Errasti, Antonio Carrera Silva, et al.(2017). Decreased Levels of Circulatig Protein S in Patients with Active Crohn’s Disease . Gastroenterology. 152. (5). p. S612. Elsevier {BV}

Latino, J.O., Udry, S., Aranda, F.M., Perés Wingeyer, S.D.A., Fernández Romero, D.S., De Larrañaga, G.F.(2017). Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: The influence of a triple positive antibody profile . Lupus. 26. (9). p. 983-988.

Chamorro, J.G., Castagnino, J.P., Aidar, O., Musella, R.M., Frías, A., Visca, M., Nogueras, M., Costa, L., Perez, A., Caradonna, F., et al.(2017). Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity . Pharmacogenetics and Genomics. 27. (10). p. 363-371.

Federico M. Aranda, Silvia D. Perés Wingeyer, Gabriela Camicia, Emilce Schneeberger, Fernando Dal Pra, María de los Ángeles Correa, Gustavo Citera, Liliana Martínez, Pablo Mannucci, Graciela Remondino, et al.(2016). Q222R polymorphism in the DNAse I gene is not associated with susceptibility to rheumatoid arthritis or to disease course in an Argentine patient cohort . The Egyptian Rheumatologist. 38. (4). p. 289--293. Elsevier {BV}

Martin ES, Schneeberger EE, Aranda FM, Peres SW, Del Carmen Valerio M, de Los Angeles Correa M, Pra FD, Martinez L, Remondino G, de Larrañaga G, et al.(2016). The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients . Clinical rheumatology.

Chamorro JG, Castagnino JP, Musella RM, Nogueras M, Frías A, Visca M, Aidar O, Costa L, de Larrañaga GF(2016). tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity . Pharmacogenetics and genomics.

Aranda F, Perés Wingeyer S, de Larrañaga G(2016). D-Dimer as a prognostic marker of morbidity and mortality among HIV patients: a call for attention . Infectious diseases (London, England).

Camicia, G., Aranda, F., Muñoz, S.A., Allievi, A., Orden, A.O., Trobo, R., Eimon, A., Barreira, J.C., Schneeberger, E., Sarano, J., et al.(2016). Association between severe disease course and nephritis with Q222R polymorphism in DNAse I gene among lupus patients: An Argentine multicenter study . Acta Reumatologica Portuguesa. 2016. (2). p. 138-144.

Aranda, F.M., Wingeyer, S.D.P., Camicia, G., Schneeberger, E., Dal Pra, F., de los Ángeles Correa, M., Citera, G., Martínez, L., Mannucci, P., Remondino, G., et al.(2016). Q222R polymorphism in the DNAse I gene is not associated with susceptibility to rheumatoid arthritis or to disease course in an Argentine patient cohort . Egyptian Rheumatologist. 38. (4). p. 289-293.

Chamorro, J.G., Castagnino, J.P., Musella, R.M., Nogueras, M., Frías, A., Visca, M., Aidar, O., Costa, L., De Larrañaga, G.F.(2016). tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity . Pharmacogenetics and Genomics. 26. (7). p. 357-361.

Aranda, F., Perés Wingeyer, S.D., Schneeberger, E., Valerio, M., Saint Martin, E., Dal Pra, F., Correa, M.de.los.A., Citera, G., Martínez, L., Mannucci, P., et al.(2016). The -308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients . International Journal of Rheumatic Diseases. 19. (5). p. 476-481.

Martin, E.S., Schneeberger, E.E., Aranda, F.M., Peres, S.W., del Carmen Valerio, M., de los Angeles Correa, M., Pra, F.D., Martinez, L., Remondino, G., de Larrañaga, G., et al.(2016). The −2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene (MCP-1) is associated with an increased risk of rheumatoid arthritis in Argentine patients . Clinical Rheumatology. 35. (12). p. 3057-3061.

Camicia G, Pozner R, de Larrañaga G(2014). Neutrophil extracellular traps in sepsis . Shock (Augusta, Ga.).

Aranda F, Perés Wingeyer SD, Schneeberger E, Valerio M, Saint Martin E, Dal Pra F, Correa Mde L, Citera G, Martínez L, Mannucci P, et al.(2014). The -308 G/A polymorphism in the tumor necrosis factor-α gene is not associated with development and progression of rheumatoid arthritis in Argentinean patients . International journal of rheumatic diseases.

Udry, S., Aranda, F.M., Latino, J.O., De Larrañaga, G.F.(2014). Paternal factor V Leiden and recurrent pregnancy loss: A new concept behind fetal genetics? . Journal of Thrombosis and Haemostasis. 12. (5). p. 666-669.

Udry, S., Aranda, F.M., Latino, J.O., de Larrañaga, G.F.(2014). Paternal factor V Leiden and recurrent pregnancy loss: A new concept behind fetal genetics?: Reply . Journal of Thrombosis and Haemostasis. 12. (10). p. 1759-1760.

Muñoz, S.A., Aranda, F., Allievi, A., Orden, A.O., Perés Wingeyer, S., Trobo, R., Alvarez, A., Eimon, A., Barreira, J.C., Schneeberger, E., et al.(2014). 4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: Focus on lupus nephritis . Clinical and Experimental Medicine. 14. (1). p. 83-89.

Camicia, G., Pozner, R., De Larrañaga, G.(2014). Neutrophil extracellular traps in sepsis . Shock. 42. (4). p. 286-294.

Berman H, Rodríguez-Pintó I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D, Shoenfeld Y, Espinosa G, Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies)(2013). Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab . Autoimmunity reviews.

Chamorro JG, Castagnino JP, Musella RM, Nogueras M, Aranda FM, Frías A, Visca M, Aidar O, Perés S, de Larrañaga GF(2013). Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs . Journal of gastroenterology and hepatology.

Udry S, Aranda F, Latino O, Larrañaga Gd(2013). [Annexins and recurrent pregnancy loss] . Medicina.

Camicia, G., De Larrañaga, G.(2013). Neutrophil extracellular traps: A 2-faced host defense mechanism,Trampas extracelulares de neutrófilos: un mecanismo de defensa con dos caras . Medicina Clinica. 140. (2). p. 70-75.

Chamorro, J.G., Castagnino, J.P., Musella, R.M., Nogueras, M., Aranda, F.M., Frías, A., Visca, M., Aidar, O., Perés, S., De Larrañaga, G.F.(2013). Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs . Journal of Gastroenterology and Hepatology (Australia). 28. (2). p. 323-328.

Muñoz SA, Aranda F, Allievi A, Orden AO, Perés Wingeyer S, Trobo R, Alvarez A, Eimon A, Barreira JC, Schneeberger E, et al.(2012). 4G/5G plasminogen activator inhibitor-1 and -308 A/G tumor necrosis factor-α promoter gene polymorphisms in Argentinean lupus patients: focus on lupus nephritis . Clinical and experimental medicine.

Chamorro JG, Castagnino JP, Musella RM, Frias A, Aranda FM, De Larrañaga GF(2012). The distribution of allelic and genotypic frequencies of N-Acetyltransferase-2 variants in an Argentine population . Journal of infection in developing countries.

Gabriela Fernanda De Larrañaga, Silvia Daniela Amanda Perés Wingeyer, Eleonora Roxana Cunto, Cristina Mabel Nogueras, Jorge Alejandro San Juan, Norberto Gomez(2012). Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina . The Journal of Infection in Developing Countries. 6. (07). Journal of Infection in Developing Countries

Perés Wingeyer SD, Cunto ER, Nogueras CM, San Juan JA, Gomez N, de Larrañaga GF(2012). Biomarkers in sepsis at time zero: intensive care unit scores, plasma measurements and polymorphisms in Argentina . Journal of infection in developing countries.

Camicia G, de Larrañaga G(2012). [Neutrophil extracellular traps: a 2-faced host defense mechanism] . Medicina clinica.

Aranda F, Wingeyer SP, Muñoz SA, Allievi A, Orden A, Trobo R, Alvarez A, Eimon A, Barreira JC, Schneeberger E, et al.(2012). The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in Argentinean patients: a multicenter study . European cytokine network.

Wingeyer, S.P., Cunto, E., Nogueras, C., Juan, J.S., Norberto, G., de Larrañaga, G.(2012). Biomarkers in sepsis at time zero: Intensive care unit scores, plasma measurements and polymorphisms in Argentina . Journal of Infection in Developing Countries. 6. (7). p. 555-562.

Aranda, F., Wingeyer, S.P., Mũnoz, S.A., Allievi, A., Orden, A., Trobo, R., Alvarez, A., Eimon, A., Barreira, J.C., Schneeberger, E., et al.(2012). The -2518 A/G polymorphism in the monocyte chemoattractant protein 1 gene is associated with the risk of developing systemic lupus erythematosus in argentinean patients: A multicenter study . European Cytokine Network. 23. (1). p. 7-11.

Chamorro, J.G., Castagnino, J.P., Musella, R.M., Frías, A., Aranda, F.M., de Larrañaga, G.F.(2012). The distribution of allelic and genotypic frequencies of N-acetyltransferase-2 variants in an Argentine population . Journal of Infection in Developing Countries. 6. (9). p. 671-674.

Wingeyer, S.D.P., Graffigna, M.N., Belli, S.H., Benetucci, J., De Larrañaga, G.F.(2012). Role of-675 4G/5G in the plasminogen activator inhibitor-1 gene and-308G/A tumor necrosis factor-α gene polymorphisms in obese argentinean patients . Genetic Testing and Molecular Biomarkers. 16. (5). p. 372-375.

Wingeyer SD, Graffigna MN, Belli SH, Benetucci J, de Larrañaga GF(2011). Role of -675 4G/5G in the plasminogen activator inhibitor-1 gene and -308G/A tumor necrosis factor-α gene polymorphisms in obese Argentinean patients . Genetic testing and molecular biomarkers.

Forastiero, R., Martinuzzo, M., De Larrañaga, G., Vega-Ostertag, M., Pierangeli, S.(2011). Anti-β2glycoprotein I antibodies from leprosy patients do not show thrombogenic effects in an in vivo animal model . Journal of Thrombosis and Haemostasis. 9. (4). p. 859-861.

Cervera R, CAPS Registry Project Group(2010). Catastrophic antiphospholipid syndrome (CAPS): update from the 'CAPS Registry' . Lupus.

Wingeyer SD, Belli SH, Graffigna MN, Levalle O, de Larrañaga GF(2010). Relationship between 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene and obesity in Argentinian Hispanic adults . Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Perés Wingeyer, S., de Larrañaga, G., Cunto, E., Fontana, L., Nogueras, C., San Juan, J.(2010). Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis . Thrombosis Research. 125. (4). p. 367-369.

Wingeyer, S.D.P., Belli, S.H., Graffigna, M.N., Levalle, O., De Larrañaga, G.F.(2010). Relationship between 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene and obesity in Argentinian Hispanic adults . Blood Coagulation and Fibrinolysis. 21. (2). p. 196-198.

Wingeyer SP, de Larrañaga G, Cunto E, Fontana L, Nogueras C, San Juan J(2009). Role of 4G/5G promoter polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1) gene in outcome of sepsis . Thrombosis research.

Graffigna MN, Belli SH, de Larrañaga G, Fainboim H, Estepo C, Peres S, García N, Levalle O(2009). [Insulin-like growth factor-binding protein-1: a new biochemical marker of nonalcoholic fatty liver disease?] . Acta gastroenterologica Latinoamericana.

Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G, Shoenfeld Y, Ingelmo M, Espinos G, Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies)(2009). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry" . Journal of autoimmunity.

Graffigna, M.N., Belli, S.H., De Larrañaga, G., Fainboim, H., Estepo, C., Peres, S., García, N., Levalle, O.(2009). Insulin-like growth factor-binding protein-1: A new biochemical marker of nonalcoholic fatty liver disease?,La proteína transportadora del factor de crecimiento insulínico Tipo 1: ¿Un nuevo marcador para la enfermedad hepática grasa no alcohólica? . Acta Gastroenterologica Latinoamericana. 39. (1). p. 30-37.

De Larrañaga, G., Bottaro, E., Martinuzzo, M., Figueroa, R., Iglesias Varela, M.L., Perés Wingeyer, S., Forastiero, R., Adamczuk, Y., Corti, M., Puga, L., et al.(2009). Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? the first case-control study . Clinical and Applied Thrombosis/Hemostasis. 15. (3). p. 340-347.

Perés Wingeyer SD, de Larrañaga GF, Belli SH, Graffigna MN, Fainboim H(2008). The range of normal values of liver enzymes in the era of metabolic syndrome: the need for a redefinition . European journal of gastroenterology & hepatology.

De Larrañaga, G., Wingeyer, S.P., Graffigna, M., Belli, S., Bendezú, K., Álvarez, S., Levalle, O., Fainboim, H.(2008). Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome . Clinical and Applied Thrombosis/Hemostasis. 14. (3). p. 319-324.

Perés Wingeyer, S.D., De Larrañaga, G.F., Belli, S.H., Graffigna, M.N., Fainboim, H.(2008). The range of normal values of liver enzymes in the era of metabolic syndrome: The need for a redefinition . European Journal of Gastroenterology and Hepatology. 20. (6). p. 589-591.

de Larrañaga G, Wingeyer SP, Graffigna M, Belli S, Bendezú K, Alvarez S, Levalle O, Fainboim H(2007). Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome . Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

de Larrañaga G, Bottaro E, Martinuzzo M, Figueroa R, Iglesias Varela ML, Perés Wingeyer S, Forastiero R, Adamczuk Y, Corti M, Puga L, et al.(2007). Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? The first case-control study . Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

de Larrañaga G, Trombetta L, Wingeyer SP, Remondino G(2006). False positive reactions in confirmatory tests for syphilis in presence of antiphospholipid antibodies: misdiagnosis with prognostic and social consequences . Dermatology online journal.

De Larrañaga, G., Trombetta, L., Wingeyer, S.P., Remondino, G.(2006). False positive reactions in confirmatory tests for syphilis in presence of antiphospholipid antibodies: Misdiagnosis with prognostic and social consequences . Dermatology Online Journal. 12. (4).

De Larrañaga, G.F., Perés Wingeyer, S.D.A., Puga, L.M., Alonso, B.S., Benetucci, J.A.(2006). Relationship between hepatitis C virus (HCV) and insulin resistance, endothelial perturbation, and platelet activation in HIV-HCV-coinfected patients under highly active antiretroviral treatment . European Journal of Clinical Microbiology and Infectious Diseases. 25. (2). p. 98-103.

de Larrañaga GF, Remondino G, Alonso BS, Voto L(2005). Soluble thrombomodulin levels among women with a history of recurrent pregnancy loss, with or without antiphospholipid antibodies . Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

De Larrañaga, G.F., Remondino, G., Alonso, B.S., Voto, L.(2005). Soluble thrombomodulin levels among women with a history of recurrent pregnancy loss, with or without antiphospholipid antibodies . Blood Coagulation and Fibrinolysis. 16. (1). p. 31-35.

De Larrañaga, G.F., Remondino, G.I., Forastiero, R.R., Cunto, E.R., Narbaitz, M., Olenchuk, A.B., Zala, N.S., San Juan, J.A.(2005). Catastrophic antiphospholipid syndrome and Kikuchi-Fujimoto disease: The first case reported . Lupus. 14. (12). p. 967-969.

Forastiero, R.R., Martinuzzo, M.E., De Larrañaga, G.F.(2005). Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies . Lupus. 14. (2). p. 129-136.

de Larrañaga G, Perés S, Benetucci J(2004). Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy . Hepatology (Baltimore, Md.).

De Larrañaga, G., Perés, S., Benetucci, J.(2004). Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy [2] . Hepatology. 40. (6). p. 1475-1476.

de Larrañaga, G., Perés, S., Puga, L., Alonso, B., Benetucci, J.(2004). Association between the acquired free protein S deficiency in HIV-infected patients with the lipid profile levels [3] . Journal of Thrombosis and Haemostasis. 2. (7). p. 1195-1197.

De Larrañaga, G., Galich, A., Puga, L., Alonso, B., Benetucci, J.(2004). Insulin resistance status is an important determinant of PAI-1 levels in HIV-infected patients, independently of the lipid profile [6] . Journal of Thrombosis and Haemostasis. 2. (3). p. 532-534.

de Larrañaga GF, Bocassi AR, Puga LM, Alonso BS, Benetucci JA(2003). Endothelial markers and HIV infection in the era of highly active antiretroviral treatment . Thrombosis research.

de Larrañaga GF, Petroni A, Deluchi G, Alonso BS, Benetucci JA(2003). Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients . Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

de Larrañaga G, Alonso B, Puga L, Benetucci J(2003). [Plasma homocysteine in human immunodeficiency virus infected patient] . Medicina.

Gabriela F de Larrañaga, Alejandro Petroni, Gabriel Deluchi, Beatriz S Alonso, Jorge A Benetucci(2003). Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients . Blood Coagulation & Fibrinolysis. 14. (1). p. 15--18. Ovid Technologies (Wolters Kluwer Health)

Forastiero, R.R., Martinuzzo, M.E., De Larrañaga, G., Broze, G.J.(2003). Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection-related antiphospholipid antibodies . Journal of Thrombosis and Haemostasis. 1. (10). p. 2250-2251.

de Larrañaga, G., Alonso, B., Puga, L., Benetucci, J.(2003). Plasma homocysteine in Human Immunodeficiency Virus infected patients,Homocisteína plasmática en infectados con el virus de la inmunodeficiencia humana . Medicina. 63. (5). p. 393-398.

De Larrañaga, G.F., Petroni, A., Deluchi, G., Alonso, B.S., Benetucci, J.A.(2003). Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients . Blood Coagulation and Fibrinolysis. 14. (1). p. 15-18.

De Larrañaga, G.F., Bocassi, A.R., Puga, L.M., Alonso, B.S., Benetucci, J.A.(2003). Endothelial markers and HIV infection in the era of highly active antiretroviral treatment . Thrombosis Research. 110. (2-3). p. 93-98.

Martinuzzo, M.E., de Larrañaga, G.F., Forastiero, R.R., Peligri, Y., Fariña, M.H., Alonso, B.S., Kordich, L.C., Carreras, L.O.(2002). Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies . Clinical and Experimental Rheumatology. 20. (4). p. 477-483.

De Larrañaga, G., Martinuzzo, M., Bocassi, A., Fressart, M.M., Forastiero, R.(2002). Heparin-platelet factor 4 induced antibodies in patients with either autoimmune or alloimmune antiphospholipid antibodies . Thrombosis and Haemostasis. 88. (2). p. 371-373.

Raul C. Rey, Gabriela de Larrañaga, Sandra Lepera, Marcela Cohen, Gustavo Saposnik, Beatriz Alonso, Roberto E.P. Sica(2001). Activated protein C resistance in patients with arterial ischemic stroke . Journal of Stroke and Cerebrovascular Diseases. 10. (3). p. 128--131. Elsevier {BV}

Rey, R.C., De Larrañaga, G., Lepera, S., Cohen, M., Saposnik, G., Alonso, B., Sica, R.E.P.(2001). Activated protein C resistance in patients with arterial ischemic stroke . Journal of Stroke and Cerebrovascular Diseases. 10. (3). p. 128-131.

De Larranaga, G.F., Forastiero, R.R., Martinuzzo, M.E., Carreras, L.O., Tsariktsian, G., Sturno, M.M., Alonso, B.S.(2000). High prevalence of antiphospholipid antibodies in leprosy: Evaluation of antigen reactivity . Lupus. 9. (8). p. 594-600.

De Larrañaga, G.F., Harris, E.N., Pierangeli, S.S., Alonso, B.S., Schroder, T., Fainboim, H.(2000). Low prevalence of autoimmune antiphospholipid antibodies in hepatic diseases,Baja prevalencia de anticuerpos antifosfolipidos autoinmunes en enfermedades hepaticas . Medicina. 60. (6). p. 919-922.

Gabriela F. de Larrañaga, Ricardo R. Forastiero, Luis O. Carreras, Beatriz S. Alonso(1999). Different Types of Antiphospholipid Antibodies in AIDS . Thrombosis Research. 96. (1). p. 19--25. Elsevier {BV}

De Larrañaga, G.F., Forastiero, R.R., Carreras, L.O., Alonso, B.S.(1999). Different types of antiphospholipid antibodies in AIDS: A comparison with syphilis and the antiphospholipid syndrome . Thrombosis Research. 96. (1). p. 19-25.

De Larranaga, G., Forastiero, R., Carreras, L.O., Zala, N., Guzman, L., Alonso, B.(1999). Acquired hypoprothrombinemia related to high titres of antiprotein-phospholipid antibodies [5] . Thrombosis and Haemostasis. 81. (2). p. 317-318.